Patients with inflammation of the joint are often excluded from cartilage repair attempts given that catabolic cytokines and proteinases (MMPs) present in the synovial fluid degrade the native ECM, and would similarly degrade any implanted tissue, predisposing treatment failure
Over time, the distribution of disease can extend or regress
For Irelands 18bn dairy industry the rise of Ozempic or other GLP-1 drugs can present challenges through a reduction in the consumption of certain dairy products but a rise in others such as cottage cheese and yoghurts
Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial
Cystine: compartmentalization within lysosomes in cystinotic leukocytes
The question at the head of this article carries a useful assumption worth surfacing before we go any further: that orforglipron and the peptide GLP-1 receptor agonists it is often lumped with are, in fact, meaningfully different in the ways that matter to a laboratory